Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Department of Justice
Pharma
Glenmark settles with US over longstanding price-fixing claims
After paying $30 million in criminal penalties last year, Glenmark has agreed to settle over claims it fixed the price of a popular cholesterol drug.
Fraiser Kansteiner
Sep 5, 2024 1:31pm
US appeals Gilead's trial win in Truvada, Descovy patent fight
Jul 9, 2024 11:00am
Merck KGaA's MilliporeSigma helps expose fraud scheme to DOJ
May 22, 2024 12:48pm
DOJ sues Regeneron for under-reporting Eylea price to Medicare
Apr 11, 2024 11:12am
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
DOJ probing BioMartin testing programs for Vimizim, Naglazyme
Feb 28, 2024 7:48am
